Trump Team Weighs Pulling Funds for Moderna Bird Flu Vaccine [Yahoo! Finance]
Moderna, Inc. (MRNA)
Last moderna, inc. earnings: 2/26 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
marinabio.com/investor-relations
Company Research
Source: Yahoo! Finance
Most Read from Bloomberg The Trump Administration Takes Aim at Transportation Research NYC's Congestion Pricing Pulls In $48.6 Million in First Month Shelters Await Billions in Federal Money for Homelessness Providers New York's Congestion Pricing Plan Faces Another Legal Showdown NYC to Shut Migrant Center in Former Hotel as Crisis Eases The review is part of a government push to examine spending on messenger RNA-based vaccines, the technology that powered Moderna's Covid vaccine. The bird flu shot contract was awarded to Moderna in the Biden administration's final days, sending the company's stock up 13% in the two days following the Jan. 17 announcement. The US is in the midst of a record-breaking bird flu outbreak that's affected
Read more
Impact Snapshot
Event Time:
MRNA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MRNA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MRNA alerts
High impacting Moderna, Inc. news events
Weekly update
A roundup of the hottest topics
MRNA
News
- Moderna, Inc. (NASDAQ: MRNA) is now covered by analysts at Citigroup Inc.. They set a "neutral" rating and a $40.00 price target on the stock.MarketBeat
- Here's Why Moderna Stock Soared 16% on Wednesday [Yahoo! Finance]Yahoo! Finance
- https://seekingalpha.com/article/4765429-moderna-insider-buy-signal [Seeking Alpha]Seeking Alpha
- Why Moderna, Inc. (MRNA) Went Up on Wednesday [Yahoo! Finance]Yahoo! Finance
- Why Moderna (MRNA) Stock Is Rallying Today [Yahoo! Finance]Yahoo! Finance
MRNA
Earnings
- 2/14/25 - Miss
MRNA
Sec Filings
- 3/11/25 - Form DEFA14A
- 3/11/25 - Form DEF
- 3/11/25 - Form ARS
- MRNA's page on the SEC website